CaroGen

[Yale Ventures @Yale_Ventures]

Constant innovation: @Yale startup @CaroGen2 adds prominent immunologists to its scientific advisory board.

Read more:
https://t.co/djMxjN0yTy

[CaroGen @CaroGen2]

Today, CaroGen announced that we are using our AVIDIO platform technology to develop a vaccine against COVID-19/SARS-CoV-2. Please see this article from the Hartford Business Journal. https://t.co/6hCA0h1uNp

[CaroGen @CaroGen2]

We'll have more announcements coming in the near future!

[CaroGen @CaroGen2]

Harry H. Penner, Jr., the former CEO of Neurogen and a serial entrepreneur, elected Chairman of the Board of Directors of CaroGen. https://t.co/QnJzYSzXGt

[bioRxiv Immunology @biorxiv_immuno]

Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B https://t.co/TLZPsoLRAk #biorxiv_immuno

[bxv_imm @bxv_imm]

Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B https://t.co/FQqDAQ13TV

[Johan Van Weyenbergh @johanvawe]

#Immunotherapy for #HBV: preclinical data #preprint

[CaroGen @CaroGen2]

CaroGen Announces Chronic Hepatitis B Immunotherapy Clinical Candidate Selection, Successful Pre-IND Interaction, U.S. Patent Issuance and SBIR Award
For more information follow our webpage.
https://t.co/KndFjIQg7D